A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe fanconi anemia and biallelic FANCD1/BRCA2 mutations

Genes Chromosomes and Cancer

Volumn 42, Issue 4, 2005, Pages 404-415

  Meyer, Stefan ^a,b,f   Fergusson, William D ^c   Oostra, Anneke B ^d   Medhurst, Annette L ^d   Waisfisz, Quinten ^d   De Winter, Johan P ^d   Chen, Fei ^d   Carr, Trevor F ^b   Clayton Smith, Jill ^c   Clancy, Tara ^c   Green, Mike ^e   Barber, Lisa ^a   Eden, Osborn B ^b   Will, Andrew M ^b   Joenje, Hans ^d   Taylor, G Malcolm ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Ctrl Manchester Manchester C ^*  (United Kingdom)

^c Academic Unit of Medical Genetics   (United Kingdom)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e CHRISTIE HOSPITAL   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3;

ARTICLE; CANCER GROWTH; CASE REPORT; CELL CULTURE; CROSS LINKING; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE CARRIER; FAMILY HISTORY; FANCONI ANEMIA; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; INHERITANCE; LEUKEMIA CELL LINE; MALE; MYELOID LEUKEMIA; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL;

ALLELES; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENES, BRCA2; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MITOMYCIN; MUTATION; NUCLEAR PROTEINS;

EID: 13944271408     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20153     Document Type: Article

References (28)

1. Alter BP. 1996. Fanconi's anemia and malignancies. Am J Hematol 53:99-110.
2. D'Andrea AD, Grompe M. 2003. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3:23-34.
3. Drexler HG, MacLeod RA. 2003. Leukemia-lymphoma cell lines as model systems for hematopoietic research. Ann Med 35:404-412.
4. Folias A, Matkovic M, Bruun D, Reid S, Hejna J, Grompe M, D'Andrea A, Moses R. 2002. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum Mol Genet 11:2591-2597.
5. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7:249-262.
6. Hirsch B, Shimamura A, Moreau L, Baldinger S, Hag-Alshiekh M, Bostrom B, Sencer S, D'Andrea AD. 2004. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103:2554-2559.
7. Hölzel M, van Diest PJ, Bier P, Wallisch M, Hoatlin ME, Joenje H, de Winter JP. 2003. FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia. J Pathol 201:198-203.
8. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606-609.
9. Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AW, De Winter JR Hoatlin ME, Kawai Y, Sasaki MS, D'Andrea AD, Kawakami Y, Joenje H. 2003. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Cancer Res 63:2688-2694.
10. Joenje H, Lo ten Foe JR, Oostra AB, van Berkel CG, Rooimans MA, Schroeder-Kurth T, Wegner RD, Gille JJ, Buchwald M, Anvert F. 1995. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 86:2156-2160.
11. Joenje H, Patel KJ. 2001. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2:446-457.
12. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. 2003. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646.
13. Kobayashi N, Saeki K, Yuo A. 2003. Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce cell cycle progression through the synthesis of c-Myc protein by internal ribosome entry site-mediated translation via phosphatidylinositol 3-kinase pathway in human factor-dependent leukemic cells. Blood 102:3186-195.
14. Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, De Winter JP, Joenje H. 2004. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103:2498-2503.
15. Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, Joenje H, Hoatlin ME, Wang W. 2003. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 23:3417-3426.
16. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, Wang W. 2003. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35:165-170.
17. ISCN. 1995. An international system for human cytogenetic nomenclature. Mitelman, F, editor. Basel, Switzerland: Karger.
18. Myers RM, Maniatis T, Lerman LS. 1987. Detection and localization of single base changes by denaturing gradient gel electrophoresis. In: Wu R, editor. Methods in enzymology. Volume 155. San Diego, CA: Academic Press. p 501-527.
19. Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D'Andrea AD. 2002. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 4:913-920.
20. Offit K, Levran O, Mullaney B, Mah K, Nafa K, Batish SD, Diotti R, Schneider H, Deffenbaugh A, Scholl T, Proud VK, Robson M, Norton L, Ellis N, Hanenberg H, Auerbach AD. 2003. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J Natl Cancer Inst 95:1548-1551.
21. Popp H, Kalb R, Fischer A, Lobitz S, Kokemohr I, Hanenberg H, Schindler D. 2003. Screening Fanconi anemia lymphoid cell lines of non-A, C, D2, E, F, G subtypes for defects in BRCA2/FANCD1. Cytogenet Genome Res 103:54-57.
22. Quentmeier H, Zaborski M, Drexler HG. 1997. The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leuk Res 21:343-350.
23. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. 2002. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414-2420.
24. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD. 2002. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109:459-472.
25. Tischkowitz MD, Hodgson SV. 2003. Fanconi anaemia. J Med Genet 40:1-10.
26. Wagner JE, Tolar J, Levran O, Scholl T, Deffenbaugh A, Satagopan J, Ben-Porat L, Mah K, Batish SD, Kutler DI, MacMillan ML, Hanenberg H, Auerbach AD. 2004. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia and Fanconi anemia. Blood 103:3226-3229.
27. Wagner TM, Hirtenlehner K, Shen P, Moeslinger R, Muhr D, Fleischmann E, Concin H, Doeller W, Haid A, Lang AH, Mayer P, Petru E, Ropp E, Langbauer G, Kubista E, Scheiner O, Underhill P, Mountain J, Stierer M, Zielinski C, Oefner P. 1999. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 8:413-423.
28. Xie Y, de Winter JP, Waisfisz Q, Nieuwint AW, Scheper RJ, Arwert F, Hoatlin ME, Ossenkoppele GJ, Schuurhuis GJ, Joenje H. 2000. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol 111:1057-1064.